BCM
WVE icon

Bayesian Capital Management’s Wave Life Sciences WVE Stock Holding History

Bayesian Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,701
Closed -$104K – 1034
2024
Q3 		$104K Buy
+12,701
New +$75.9K 0.01% 603
2021
Q1 		– Sell
-12,375
Closed -$97K – 712
2020
Q4 		$97K Buy
+12,375
New +$104K 0.03% 416

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Bayesian Capital Management's WVE Position: Q4 2024 in Review

Bayesian Capital Management sold out of Wave Life Sciences (WVE) in Q4 2024, closing a stake of 12,701 shares — an estimated $104K sold.

Bayesian Capital Management first reported a position in WVE in Q4 2020 and held it in 2 quarters. The position peaked at $104K in Q3 2024. 183 funds tracked by Wall St. Rank hold WVE as of Q4 2024.

  • Bayesian Capital Management reported no remaining Wave Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 12,701 Wave Life Sciences shares in Q4 2024, an estimated $104K.
  • Bayesian Capital Management first reported a position in Wave Life Sciences in Q4 2020 and held it in 2 quarters.
  • Bayesian Capital Management's Wave Life Sciences position peaked at $104K in Q3 2024.
  • 183 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2024.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.